The RPAP3-Cterminal domain identifies R2TP-like quaternary chaperones by Maurizy, Chloé et al.
HAL Id: hal-02343521
https://hal.archives-ouvertes.fr/hal-02343521
Submitted on 24 Jun 2020
HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.
L’archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d’enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.
Distributed under a Creative Commons Attribution| 4.0 International License
The RPAP3-Cterminal domain identifies R2TP-like
quaternary chaperones
Chloé Maurizy, Marc Quinternet, Yoann Abel, Céline Verheggen, Paulo Santo,
Maxime Bourguet, Ana C.F. Paiva, Benoît Bragantini, Marie-Eve Chagot,
Marie-Cécile Robert, et al.
To cite this version:
Chloé Maurizy, Marc Quinternet, Yoann Abel, Céline Verheggen, Paulo Santo, et al.. The RPAP3-
Cterminal domain identifies R2TP-like quaternary chaperones. Nature Communications, Nature Pub-
lishing Group, 2018, 9 (1), pp.2093. ￿10.1038/s41467-018-04431-1￿. ￿hal-02343521￿
ARTICLE
The RPAP3-Cterminal domain identifies R2TP-like
quaternary chaperones
Chloé Maurizy1,2, Marc Quinternet3, Yoann Abel1,2, Céline Verheggen1,2, Paulo E. Santo4,5, Maxime Bourguet6,
Ana C.F. Paiva4,5, Benoît Bragantini7, Marie-Eve Chagot7, Marie-Cécile Robert1,2, Claire Abeza1,2, Philippe Fabre7,
Philippe Fort8, Franck Vandermoere9, Pedro M.F. Sousa4,5, Jean-Christophe Rain10, Bruno Charpentier7,
Sarah Cianférani6, Tiago M. Bandeiras4,5, Bérengère Pradet-Balade8, Xavier Manival7 & Edouard Bertrand1,2
R2TP is an HSP90 co-chaperone that assembles important macro-molecular machineries. It
is composed of an RPAP3-PIH1D1 heterodimer, which binds the two essential AAA+ATPases
RUVBL1/RUVBL2. Here, we resolve the structure of the conserved C-terminal domain of
RPAP3, and we show that it directly binds RUVBL1/RUVBL2 hexamers. The human genome
encodes two other proteins bearing RPAP3-C-terminal-like domains and three containing
PIH-like domains. Systematic interaction analyses show that one RPAP3-like protein, SPAG1,
binds PIH1D2 and RUVBL1/2 to form an R2TP-like complex termed R2SP. This co-chaperone
is enriched in testis and among 68 of the potential clients identified, some are expressed in
testis and others are ubiquitous. One substrate is liprin-α2, which organizes large signaling
complexes. Remarkably, R2SP is required for liprin-α2 expression and for the assembly of
liprin-α2 complexes, indicating that R2SP functions in quaternary protein folding. Effects are
stronger at 32 °C, suggesting that R2SP could help compensating the lower temperate of
testis.
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The R2TP complex was discovered in S. cerevisiae as anHSP90 co-factor1. R2TP is an unusual co-chaperonebecause it appears specialized in quaternary protein fold-
ing, and in particular in the assembly of key cellular machineries
important for cell growth2. Important R2TP clients are the small
nucleolar ribonucleoprotein particles (snoRNPs), which are
required for ribosomal RNAs maturation3. More recently, other
substrates were described, including the U4 and U5 spliceosomal
snRNAs4–6, the nuclear RNA polymerases7–9, and the family of
PI3K-like kinases (PIKKs), which comprises mTOR, DNA-PK,
ATR, ATM, SMG1 and TRRAP10,11. Given the role of these cli-
ents in cell growth and proliferation, it was hypothesized that
R2TP mediates some of the tumorigenic effects elicited by
HSP9012. Newly identified clients involved in DNA damage
response corroborate this possibility13.
In humans, R2TP is composed of a core that associates with
prefoldins and additional factors to form the R2TP/Prefoldin-like
complex, recently renamed PAQosome2,7–9. The R2TP core is
composed of four subunits (Fig. 1a): PIH1D1, RPAP3, and the
two related AAA+ATPases RUVBL1 and RUVBL2 (also called
Pontin and Reptin). RPAP3 directly binds HSP90 and forms a
stable heterodimer with PIH1D114,15. These components are
believed to function as adapter and regulatory factors, while
RUVBL1 and RUVBL2 are catalytic components that likely
possess a chaperone activity16. The analysis of snoRNP biogenesis
suggests that R2TP functions through a stepwise process, where
HSP90 stabilizes clients before their assembly, followed by the
independent recruitment of several snoRNP components by
R2TP, and ending in the loading of RUVBL1/2 on the client
complex17. The molecular role of RUVBL1 and RUVBL2 still
remains elusive. Structural studies showed that they form hex-
americ rings typical for this class of enzymes18. In addition, they
contain an insertion called domain II, which protrudes from the
ATPase ring and forms a flexible structure whose conformation
depends on the presence and nature of bound nucleotides19,20.
RUVBL1/2 make ATP-dependent contacts with some cofactors
and client proteins21,22, suggesting that ATP loading and
hydrolysis may act as a switch to control the binding and release
of clients. Accordingly, it has been proposed that RUVBL1/
2 stabilize interactions between subunits of target complexes17, or,
alternatively, that they stimulate the dissociation of specific
assembly factors23. Recent structural analyses showed that
RUVBL1/2 cycle between hexameric and dodecameric forms,
with client binding promoting dimerization of the hexamer, and
ATP hydrolysis dissociation of the dodecamer16. This provides a
glimpse of how these enzymes may chaperone their clients.
Structural studies revealed that PIH1D1 has two domains. Its
N-terminal region harbors the conserved PIH domain that pos-
sesses a phospho-peptide binding pocket responsible for recog-
nizing some substrates14,15. Its C-terminal region folds as a CS
domain and mediates hetero-dimerization with RPAP314,15,24.
RPAP3 has a C-terminal domain of unknown function (RPAP3-
Cter), and a middle region composed of six tetratricopeptide
repeats (TPR) arranged in two consecutive domains (Fig. 1b).
Structural studies showed that they bind HSP90 through five
conserved residues forming a carboxylate clamp, which catches
the last C-terminal residues of the chaperone (-MEEVD15,25). A
recent cryo-EM structure of the yeast R2TP revealed that a single
copy of the Tap1p:Pih1p dimer binds an hetero-hexamer of
Rvb1/2 (the yeast homologs of RPAP3, PIH1D1 and RUVBL1/2,
respectively26,27). This interaction involves the DII domain of the
ATPases and the linker separating the PIH and CS domains of
Pih1p26–28.
In this study, we elucidate the 3D structure of the RPAP3 C-
terminal domain and we show that it binds directly the RUVBL1/
2 ATPases. A similar domain is also present in a human protein
called SPAG1, and we demonstrate that it forms an R2TP-like
complex that functions in quaternary protein folding.
Results
The RPAP3 C-ter domain co-evolved with PIH-domain pro-
teins. Although extensive structural studies have been performed
with R2TP proteins2, the structure and function of RPAP3-Cter is
unknown. This domain is absent in the S. cerevisiae homolog of
RPAP3, and we thus performed an evolutionary analysis (Fig. 1c).
Besides RPAP3, the human genome encodes two proteins har-
boring a RPAP3-Cter domain: SPAG1, which contains three TPR
domains, and CCDC103, which has a N-terminal dynein
attachment domain. Proteins with both an RPAP3-Cter and a
TPR domain occur in all eukaryotic lineages (Fig. 1c; blue dots in
the RPAP3_C column). A single such protein was likely present
at the root of Eukaryotes, and a duplication event having
occurred between Amoebozoa and Opisthokonta (Fungi and
Metazoa) generated RPAP3 and SPAG1. The human genome
encodes four proteins with PIH domains: PIH1D1-3 and
DNAAF2 (also known as Kintoun). DNAAF2 associates with
DYX1C129, a CS- and TPR- containing protein that we included
in our analysis. Most eukaryotic lineages encode three PIH-
proteins and one DYXC1 ortholog. These proteins are thus of
ancient origin, as previously noted30. Interestingly, the duplica-
tion of the RPAP3 ancestor is mimicked by a similar con-
temporary duplication of the ancestor of PIH1D1, which
generated PIH1D1 and PIH1D2. Note that neither RUVBL1/2
nor other HSP90 co-chaperone were duplicated (Fig. 1c). Alto-
gether, this analysis indicates that the ancestral form of RPAP3
had both TPR and RPAP3-Cter domains, suggesting an impor-
tant function for this domain. This protein further co-evolved
with the ancestor of PIH1D1, pointing to a link with R2TP.
The NMR structure of RPAP3-Cter reveals a helical 3D fold.
To get more information on RPAP3-Cter, we performed struc-
tural studies. We expressed fragments 535–665 and 547–665 of
human RPAP3. Only the largest domain, i.e., RPAP3535-665, was
soluble after expression and purification from E. coli (Supple-
mentary Fig. 1A, B). Using NMR, the intensity and distribution of
peaks in the 1H-15N HSQC spectrum revealed a properly folded
domain (Supplementary Fig. 1C). We obtained a well-resolved set
of 20 water-refined structures (Table 1), revealing that this
domain is composed of 8 α-helices that pack together to form a
globular object (Fig. 1d–f). Interestingly, the residues 541–548
form a loop that protects several hydrophobic amino-acids from
solvent, including Leu542, Pro543, Ile545, and Pro546 (Supple-
mentary Fig. 1D). This loop contributes to the solubility of
RPAP3-Cter since its truncation in RPAP3547-665 leads to protein
aggregation. We submitted our structure to the DALI server to
search for potential structural homologs. No strong candidate
could be identified using a top DALI Z-score below 8, with a
mean RMSD and identity percentage of 3.6 Å and 9.7%, respec-
tively. We concluded that RPAP3-Cter adopts a 3D fold, linked to
an uncharacterized biological function.
RPAP3-Cter associates with RUVBL1/2 and some R2TP cli-
ents. To get insights into the function of RPAP3-Cter, we char-
acterized its partners by performing a proteomic analysis in
human cells. We fused this domain to GFP and stably expressed it
in HeLa cells using site-specific Flp-In integration. Following
differential labeling of GFP-RPAP3-Cter and control cells with
isotopic amino-acids (SILAC), whole cell extracts were immuno-
precipitated (IP) with anti-GFP antibodies and pellets were sub-
jected to quantitative mass-spectrometry analysis (Fig. 2a). About
20 proteins associated with RPAP3-Cter with high abundance
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Fig. 1 Solution structure of the C-terminal domain of human RPAP3 a Schematic representation of the human R2TP complex. b Domain architecture of
RPAP3 (numbering corresponds to amino-acids of isoform 1). c Conservation of RPAP3 and PIH repertoires across Eukaryotes. Members in which TPR
(Pfam: 13414) or Dynein attachment (Pfam: 15867) domains are associated to the canonical RPAP3_C are colored as indicated at the left. Clades or species
that have lost flagella or in which cilia are not motile are in gray background. Members that were not found are indicated by x. d Backbone view of the
superposition of the best 20 NMR structures of human RPAP3-Cter, with α-helices indicated in violet. e Sequence of RPAP3-Cter, with corresponding α-
helices. f Backbone orthogonal views (180 °C) of RPAP3-Cter structure in ribbon representation with corresponding α-helices
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(intensity) and specificity (SILAC ratio). The top hits were
RUVBL1/2, while the others belonged to several classes: (i)
known R2TP clients (SHQ1 and NOP58 for snoRNPs, PRPF8,
and other U5 proteins for snRNAs, POLR2A for RNA poly-
merase II); (ii) known R2TP cofactors (ZNHIT2) and/or
RUVBL1/2 partners (C12ORF45, C2ORF44, DPCD)6,17,21; (iii)
PAQosome subunit (PFDN2)2; and (iv) chaperones (HSP70
isoforms and its regulator BAG2). Overall, these data suggest that
RPAP3-Cter may play an important role in interacting with
RUVBL1/2 and some R2TP clients.
RPAP3-Cter directly binds RUVBL1/2. We then performed
pairwise yeast two-hybrid assays (Y2H) between RPAP3-Cter and
its putative partners (Supplementary Fig. 2A). We detected a
positive signal with RUVBL2, but not with the other tested pro-
teins. To determine whether this interaction is direct, we used
recombinant proteins for in vitro binding assays. RUVBL1/2 were
co-expressed in E. coli and they purified predominantly as a
dodecamer (see below). We then assessed the binding to RPAP3-
Cter using NMR spectroscopy. We took advantage of the 13C-
labeling to monitor the effect of RUVBL1/2 on the methyl groups
of RPAP3-Cter. Indeed, methyl groups are able to provide strong
signals even at low protein concentrations and/or basic pHs31.
The NMR signal of 13C-labeled RPAP3-Cter decreased dramati-
cally in presence of RUVBL1/2 hetero-multimers (Fig. 2b), while
only minor effects were seen with RUVBL1 or RUVBL2 alone
(Supplementary Fig. 2B). Next, we used SPR and observed robust
interactions between RPAP3-Cter and RUVBL1/2 hetero-
multimers (Fig. 2c), with a KD of 4.2 nM in a 1:1 interaction
model calculation (Table 2). These data demonstrated that
RPAP3-Cter binds heteromeric forms of RUVBL1/2.
RUVBL1/2 cycle between hetero-hexamers and hetero-
dodecamers20, and we thus addressed the stoichiometry of the
interaction. First, we co-expressed RPAP3-Cter with RUVBL1/2
in E. coli and analyzed the complex by gel-filtration (Fig. 2d, e).
The eluting volumes of RUVBL1/2 alone and RUVBL1/2:RPAP3-
Cter corresponded to molecular masses of dodecameric and
hexameric forms of RUVBL1/2, respectively. Next, we performed
mass spectrometry analysis under non-denaturing conditions
(native MS), of either RUVBL1/2 alone, or RUVBL1/2 co-
purified with recombinant RPAP3-Cter (Fig. 2f). In the free state,
RUVBL1/2 formed hetero-hexameric and hetero-dodecameric
complexes, but hexameric forms became largely dominant upon
RPAP3-Cter binding. Note also that one hexamer can bind
multiple RPAP3-Cter domains. These data indicate that RPAP3-
Cter binds predominantly RUVBL1/2 hetero-hexamers.
Next, we analyzed the binding of RPAP3-Cter to RUVBL
mutants altered in their ATPase cycle. For this, we turned to
LUMIER interaction experiments. In this quantitative co-IP
assay, the prey and bait proteins are respectively fused to Renilla
luciferase (RL) and FLAG-tagged Firefly luciferase (3xFLAG-
FFL). Following transient expression in human HEK293 cells, the
bait is IP’ed with anti-FLAG antibodies, or without antibodies as
control. The RL and FFL luciferase activities are then measured in
the input and pellet, and the co-IP efficiency is expressed as the
percent of prey co-immuno-precipitated, relative to that of the
bait, providing a direct measurement of binding efficiencies
(Supplementary Fig. 2D). In these experiments, we used canonical
mutations of AAA+ATPases32, expected to prevent nucleotide
binding (K to M mutant in the Walker A domain), nucleotide
hydrolysis (E to Q in the Walker B-domain), or coupling between
adjacent monomers (R to E in the Arg finger). The effect of
several of these mutations was previously validated using the
Chaetomium thermophilum orthologs of RUVBL1 and
RUVBL220. Interestingly, while the K-M and R-E mutations
had little effects on the association of either RUVBL1 or RUVBL2
with RPAP3-Cter, the E-Q mutations diminished binding
(Supplementary Fig. 2D). Taken together, these data indicated
that RPAP3-Cter made a direct, high-affinity interaction with
hexameric RUVBL1/2. This interaction did not require nucleotide
and was weakened in mutants deficient in ATP hydrolysis.
RPAP3-Cter binds R2TP clients through RUVBL1/2. Our
proteomic analysis of RPAP3-Cter showed that it binds not only
RUVBL1/2, but also a range of R2TP clients. To test whether
these latter interactions depend on RUVBL1/2, we generated a
series of RPAP3-Cter mutants. Structure-guided analysis selected
solvent-exposed residues potentially involved in RUVBL1/2
interaction (Supplementary Fig. 3A, B). Alanine mutants were
screened by Y2H assays, and two of them indeed lost interaction
with RUVBL2 (Fig. 3a): R623A-M626A (Mut1) and F630A-
S632A (Mut2). Both mutants localized similar to wild-type
RPAP3-Cter (Supplementary Fig. 3C), suggesting no major
alteration. The mutated residues are conserved across evolution
(Supplementary Fig. 3D). They were located next to each other in
the 3D structure of RPAP3-Cter (Fig. 3b), suggesting that they
may constitute a conserved binding site for RUVBL1/2. LUMIER
interaction assays confirmed the Y2H data, as both RPAP3-Cter
Mut1 and Mut2 lost interaction with RUVBL1 and RUVBL2
(Fig. 3c). Next, we performed SILAC quantitative proteomic
analyses of the RPAP3-Cter mutants. Remarkably, both mutants
lost all of the RPAP3-Cter partners identified previously (Fig. 3d,
e), with the exception of SHQ1 that remained weakly bound to
RPAP3-Cter Mut1. Taken together, these data suggest that
RUVBL1/2 are required for the association of RPAP3-Cter with
its other partners.
Table 1 NMR and refinement statistics for top-20
RPAP3535-665 structures
RPAP3535-665
NMR distance and dihedral constraints
Distance constraints
Total NOE 3707
Intra-residue 855
Inter-residue 2852
Sequential (|i – j|= 1) 849
Medium-range (|i – j|≤ 4) 1033
Long-range (|i – j|≥ 5) 970
Total dihedral angle restraints 230
ϕ 110
ψ 120
Structure statistics after AMBER refinement
Violations
Distance constraints (Å) 0.10 ± 0.03
Dihedral angle constraints (°) 6.70 ± 1.94
Max. dihedral angle violation (°) 9.99
Max. distance constraint violation (Å) 0.14
Violation occurrences
Distances constraints ( > 0.2 Å) 0
Dihedral angle constraints ( > 5°) 1.30 ± 1.26
R.m.s. deviations from idealized geometry
Bond lengths (Å) 0.013 ± 0.00
Bond angles (°) 1.85 ± 0.05
R.m.s. deviation to best structurea (Å)
All heavy atoms 1.33 ± 0.29
All backbone atoms 0.98 ± 0.38
Heavy atoms in secondary structures 0.94 ± 0.07
Backbone atoms in secondary structures 0.37 ± 0.05
aPairwise r.m.s. deviation was calculated among 20 refined structures
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Identification of RPAP3-like/PIH-like complexes. As described
above, the human genome encodes two other proteins bearing
RPAP3-Cter-like domains, SPAG1 and CCDC103, and three
others containing PIH domains, PIH1D2, PIH1D3 and DNAAF2
(Fig. 1c, Fig. 4a). This suggested that these proteins could form
R2TP-like complexes, by associating to each other and with
RUVBL1/2 through their RPAP3-Cter-like domains. To test this
possibility, we first performed systematic pairwise LUMIER co-IP
assays between RPAP3-like and PIH-like proteins (Fig. 4b). In
these tests, we also added DYX1C1 because this protein associates
with DNAAF229 and bears some structural features of RPAP3
and PIH1D1 (e.g., TPR and CS domains), although it lacks PIH
and RPAP3-Cter domains. We also included the known splicing
isoforms of DYX1C1 and RPAP3, including the RPAP3 isoform 2
that does not interact with PIH1D133. Finally, we added HSP70,
HSP90, and STIP1, a factor promoting the transfer of clients from
HSP70 to HSP9034. These proteins were fused at their N-termini
to Renilla luciferase or to 3xFLAG-Firefly luciferase. The plasmids
were transiently transfected in HEK293 cells, and LUMIER IPs
were performed (Fig. 4b). As above, the interaction strength was
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expressed as the fraction of co-IP’ed prey protein normalized to
that of the bait. Negative controls included four unrelated pro-
teins, which were tested against all the RPAP3-like and PIH-like
proteins (Supplementary Fig. 4A). This allowed us to rigorously
identify specific interactions (see Methods). These experiments
revealed that all the TPR-containing proteins interacted with
HSP70, HSP90 and STIP1, although the co-IP efficiency was low
(Fig. 4b and S4B). This could be due to a low affinity or to the fact
that HSPs have many partners that potentially compete with baits
in extracts. Most interestingly, we uncovered three strong asso-
ciations between RPAP3-like and PIH-like proteins (30–40% of
co-IP efficiencies): RPAP3-iso-1 with PIH1D1, DYX1C1-iso-a
with DNAAF2, and SPAG1 with PIH1D2. Two other strong
interactions were found, between DYX1C1-iso-c and PIH1D3,
and between DNAAF2 and SPAG1, although the IP efficiencies
were 5–10 times less than for the previous couples (4–8% of co-IP
efficiencies). Finally, a number of weak but significant interac-
tions were also found (Fig. 4b and S4C), suggesting that addi-
tional PIH1D1-like/RPAP3-like pairs may also form, albeit at low
efficiencies.
PIH1D2 facilitates the binding of SPAG1 to RUVBL1/2. We
then tested whether SPAG1 and CCDC103 would bind RUVBL1/
2, also using LUMIER assays (Fig. 4c). SPAG1, RPAP3-iso-1 and
iso-2 interacted with both RUVBL proteins, while CCDC103 did
not. Surprisingly however, the isolated C-terminal domain of
SPAG1 failed to interact with RUVBL1 or RUVBL2. The C-
terminal domains of RPAP3, SPAG1, and CCDC103 have an
overall identity of only 25%, and the sequence differences may
modulate their affinity for RUVBL1/2, from a high affinity
binding for RPAP3-Cter, to a low or no binding for SPAG1-Cter
and CCDC103-Cter. Indeed, the amino-acids required for the
binding of RPAP3-Cter to RUVBL1/2 are not strictly conserved
in SPAG1 and CCDC103 (Supplementary Fig. 3B). Since the full-
length SPAG1 protein bound better to RUVBL1/2 than the iso-
lated SPAG1-Cter domain, we further tested whether its PIH1D2
partner would enhance binding. We repeated the LUMIER assay
in presence of co-expressed, untagged PIH1D2 (Fig. 5a). Indeed,
PIH1D2 increased the binding of SPAG1 to RUVBL1 and
RUVBL2 by nearly 3-fold, achieving a binding efficiency similar
to that of full-length RPAP3. Taken together, these data indicate
that SPAG1 binds RUVBL1/2 and that the binding determinants
likely include several regions within SPAG1 and PIH1D2.
This result prompted us to test whether the PIH-like proteins
would interact with RUVBL1/2. LUMIER assays indicated that
significant interactions could be detected (Supplementary
Fig. 4D), but at a low level (5–20 fold weaker than with RPAP3).
Human cells contain several complexes related to R2TP. The
LUMIER assays indicate that SPAG1 can interact with PIH1D2
and RUVBL1/2, possibly forming a complex similar to R2TP. To
obtain direct evidence that this complex exists, and to determine
whether additional R2TP-like complexes may form, we turned to
quantitative SILAC proteomics. We fused GFP to PIH1D2,
PIH1D3, DNAAF2, and CCDC103, stably expressed the fusions
in HeLa cells and used them as baits in proteomic experiments
(Fig. 5b and Supplementary Data 1). We did not find any partner
for GFP-CCDC103. For GFP-PIH1D3, we found a strong asso-
ciation with LRIF1, a nuclear factor enriched in testis. Only
minute amounts of RUVBL1/2 were detected, in agreement with
the weak interaction observed in the LUMIER assays. DYX1C1-
iso-c was also not detected, possibly because of its low abundance
in HeLa cells (Gtex dataset35). For GFP-DNAAF2, we found a
strong association with DYX1C1-iso-a, and again a weak binding
to RUVBL1 and RUVBL2 that agreed with the LUMIER assays
(Fig. 4b and S4C). In the GFP-PIH1D2 IP, the three most pro-
minent proteins were SPAG1, RUVBL1 and RUVBL2, all found
with both a high specificity and abundance (Fig. 5b). HSP70 and
its regulator BAG2 were also significantly enriched. This indi-
cated the existence of an R2TP-like complex containing PIH1D2,
SPAG1, RUVBL1/2, which associated with HSP70 chaperones.
The other GFP-PIH1D2 partners found in this experiment were
involved in a variety of processes ranging from metabolism to
RNA processing, and may represent clients of this chaperone
system. No prefoldin nor prefoldin-like proteins were detected,
Fig. 2 RPAP3-Cter interacts with RUVBL1/2 hexamers. a SILAC proteomic analysis of RPAP3-Cter. The graph depicts the proteins identified in anti-GFP
immuno-precipitates of HeLa cells expressing GFP-RPAP3-Cter. Each dot is a protein and the color code is indicated below the graph. X-axis: protein
abundance (Log10 of signal intensity); y-axis: enrichment over a control IP (Log2 of SILAC ratio). b NMR interaction analysis of RPAP3-Cter with
recombinant RUVBL1/2 complex. The graph depicts 1D NMR METHYL-SOFAST-HMQC spectra in the methyl region of 13C-labeled RPAP3-Cter alone (top
lane) or mixed with recombinant RUVBL1/2 complex (bottom lane). Intensity of the NMR signal (arbitrary units, Y-axis) is plotted against the 1H chemical
shift (in ppm, X-axis). c SPR binding assays of RPAP3-Cter with RUVBL1/2. The graph depicts the response upon injecting the RUVBL1/2 complex (t= 0 s),
or upon washing (t= 300 s), on immobilized RPAP3-Cter. X-axis: time (s); Y-axis: response (arbitrary units). These data have been obtained with the same
batch of RUVBL1/2 complex as in the control experiment (Fig. S2E, F). d Chromatographic analysis of the RUVBL complexes. The graph depicts the
chromatograms of purified RUVBL1–RUVBL2 (dashed gray, left Y axis) or RUVBL1-RUVBL2-RPAP3-Cter (black line, right Y axis), on a Superose 6 16/70
XK. X-axis: elution volume; Y-axis: absorbance. e Electrophoresis of the purified RUVBL1–RUVBL2–RPAP3–Cter complex. The gel shows the peak fraction
of the complex eluted from the column (black line in d), with a purity estimated to ~95 %. Lane 1: Precision Plus Protein Unstained Standards (Biorad); Lane
2: denatured RUVBL1–RUVBL2–RPAP3–Cter complex. Black and white arrows: RUVBL1 and RUVBL2 (52 and 53 kDa, respectively); gray arrow: RPAP3-Cter
(15 kDa). f Native mass spectrometry analysis of recombinant RUVBL complexes. The upper mass spectrum presents the purified RUVBL1/2 complex. The
bottom mass spectrum presents the same complex after addition of RPAP3-Cter. Y-axis: signal intensity; X-axis: m/z. Insets: zoom over the 8000–9000
m/z region. Schematics depict the complex observed. Blue: RUVBL proteins; red: RPAP3-Cter
Table 2 RUVBL1/2:RPAP3–Cter affinity and kinetic interaction parameters determined by SPR
His_RUVBL1_Flag_RUVBL2 interaction with immobilized RPAP3-Cter
KD (M) kd (s−1) ka (M−1 s−1) na
4.18×10 −9 ± 1.96×10 −9 1.12×10 −3 ± 2.58×10 −4 2.97×10 5 ± 6.35×10 4 3
an stands for triplicate
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but we noted that an interaction of SPAG1 with WDR92 has been
previously described21.
Collectively, the LUMIER and proteomic data thus defines
three types of complexes related to R2TP (Fig. 5c). A first
complex is composed of RPAP3-iso-2 in association with
RUVBL1/2. This complex is identical to the canonical R2TP
except that it lacks PIH1D1, and was thus named R2T. A second
complex comprises SPAG1, PIH1D2 and RUVBL1/2. This
complex shares an organization similar to R2TP and was named
R2SP. Another related complex could form with SPAG1,
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Fig. 3 The RPAP3 C-terminal domain interacts with R2TP clients via RUVBL1/2 multimers. a Yeast two-hybrid analysis of interactions between RUVBL2
and RPAP3-Cter mutants. Alix is a negative control. ***: strong interaction; **: medium; *: weak; −: no interaction. b Molecular surface representation of
RPAP3-Cter structure by specifying the location of the mutants that lost interaction with RUVBL1/2. c LUMIER assay showing the in vivo interaction
between RPAP3-Cter and RUVBL1/2 mutant proteins. Top panel: schematic representation of the assay. Bottom panel: graph plotting the IP efficiency of
the indicated proteins. The values are the IP efficiencies of the co-precipitation of the RL fusion proteins (IP/Input), normalized by the IP/Input values
obtained with the anti-FLAG IP of the 3xFLAG-FFL fusion protein. Error bars: standard deviation. Stars: values significantly greater than six-times the mean
value obtained in the control IPs without anti-FLAG antibody (Ct). **p-value < 0.001 (Z-test). d,e SILAC proteomic analysis of the partners of RPAP3-Cter-
Mut1 and RPAP3-Cter-Mut2, respectively. Legend as in Fig. 2a
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DNAAF2 and RUVBL1/2 (i.e., an R2SD complex). However, this
complex remains hypothetical since it was detected in LUMIER
but not in proteomic experiments. Finally, we observed two
heterodimers containing a PIH-like protein associated with a
DYX1C1 isoform: DNAAF2/DYX1C1-iso-a and PIH1D3/
DYX1C1-iso-c. These interactions were previously reported29,36,
but the isoform specificity of DYX1C1 was not known.
The occurrence and composition of these complexes is
corroborated by our evolutionary analyses (Fig. 1c). The parallel
duplication leading to RPAP3 and SPAG1 on one side, and PIH1D1
and PIH1D2 on the other, is consistent with their respective
incorporation into R2TP and R2SP. Similarly, some species contain
an RPAP3 ortholog but lack a PIH1D1/PIH1D2 gene, thus
mirroring the existence of R2T in human cells. The frequent co-
occurrence of DYX1C1 with either DNAAF2 or PIH1D3 is also
consistent with the association observed for the human proteins.
R2TP-like components are enriched in testis. To gain insights
into the function of these R2TP-related complexes, fluorescent
microscopy was performed with the stable cells expressing the
GFP-tagged proteins. These proteins localized to different cellular
areas, suggesting specialized functions (Supplementary Fig. 5).
Interestingly, DYX1C1-iso-c was nuclear and concentrated in
punctate structures, as did its partner PIH1D3. It is also worth
noting that RPAP3-iso-2 was mainly nuclear while RPAP3-iso-1
was mainly cytoplasmic. Thus, alternative splicing determines not
only the partners but also the localization of these proteins.
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Fig. 4 RPAP3-like and PIH1-like proteins interact with each other. a Architecture of the human proteins containing a RPAP3-Cterminal domain (RPAP3-C),
or a PIH domain (PIH). Coiled-coil (CC), CHORD-containing proteins and SGT1 domain (CS) and TPR domains (TPR) are also indicated. Different splicing
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percent of the efficiencies obtained with the 3xFLAG-FFL fusions. p-values are shown in Supplementary Fig. 4C. c LUMIER interaction assays between RL-
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Next, we examined existing data to determine in which tissues
these factors are expressed (Gtex dataset35; Supplementary
Fig. 6A). The expression patterns of RUVBL1, RPAP3, and
PIH1D1 looked similar to each other, with a rather ubiquitous
expression. DNAAF2 and SPAG1 were also broadly expressed,
but with a moderate enrichment in testis. Interestingly, PIH1D2,
PIH1D3, and RUVBL2 were highly expressed in testis, suggesting
an important role in this organ.
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Fig. 5 Identification of R2TP-like complexes. a LUMIER interaction assays between SPAG1 and RUVBL1/2. Legend as in Fig. 3c excepted that an untagged
PIH1D2 was co-expressed (lanes+), or SMD1 as control (lanes−). b SILAC proteomic analysis of the partners of GFP-PIH1D2, GFP-DNAAF2, GFP-
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PIH1D2 has both ubiquitous and testis-enriched partners. To
characterize the function of R2SP, we first searched for partners
by performing yeast two-hybrid screens using PIH1D2 as bait.
Given its expression pattern, we screened two human libraries,
from lung cancer cell lines and from testis (Fig. 6a). The screens
revealed a total of >60 potential partners (46 from the lung and 32
from testis; Fig. 6a and Supplementary Data 2). Nine proteins
were found in both libraries, including SPAG1, indicating the
high quality of the screens. These PIH1D2 partners are involved
in a variety of functions, ranging from DNA metabolism, tran-
scription and RNA processing, and up to cytoskeletal organiza-
tion, membrane-related processes and trafficking.
Next, we selected 16 proteins to test LUMIER assays and could
validate most of them (Fig. 6b). Taken together, these data
demonstrated that PIH1D2 has a range of partners involved in a
variety of processes. Some partners were enriched in testis and
others were ubiquitous (Gtex dataset35, Fig. 6b).
R2SP facilitates quaternary protein folding. Next, we tested
whether R2SP has a chaperone activity toward its partners. Since
PIH1D2 is poorly expressed in HeLa cells, in contrast to the other
components of R2SP (Supplementary Fig. 6B), we generated
HeLa cells stably expressing GFP-PIH1D2, and thus having a
fully assembled R2SP complex (see Fig. 5b). To measure its
chaperone activity, we fused to Firefly luciferase the PIH1D2
partners previously identified, and we transiently transfected
them in HeLa-PIH1D2 and parental HeLa cells. Remarkably, five
fusions were significantly more expressed in presence of GFP-
PIH1D2, reaching a threefold increase in one case (Fig. 7a). These
were PPFIA2 (liprin-α2), ZBTB1, TCP11, PATL1 and PIK3CB. In
contrast, the expression of a broad series of control proteins,
including unrelated factors (Alix, FFL) or known R2TP-substrates
(EFTUD2, PRPF31, NOP58), was identical in both cell lines
(Fig. 7a). Next, we repeated the experiments at 32 °C, the optimal
temperature of testis where PIH1D2 is highly expressed. The
effects of R2SP on proteins levels were generally more important
at this temperature. Altogether, this suggested that R2SP
enhanced expression of some of its partners and had a stronger
effect at the testis temperature.
Since R2TP is involved in the assembly of its target complexes2,
we hypothesized that R2SP could do the same. To test this, we
focused on liprin-α2 (PPFIA2). Indeed, this is the strongest
binder of PIH1D2 and it is also the most sensitive to the presence
of PIH1D2. In addition, liprins are important scaffolding
molecules that bring together a diverse set of factors in order to
control cell adhesion, cell migration, and organization of the
active synaptic zone37. Liprins possess a long coiled-coil domain
at their N-terminus, followed by a linker and three Sterile Alpha
Motif domains (SAM). The coiled-coil domain of liprin-α2 can
dimerize or heteromerize with liprin-α1 and α338. This domain
also binds several proteins, including RIMS1, a protein involved
in the docking of exocytic vesicles37,39. The SAM domain of
liprin-α2 interacts with the kinase CASK, as well as with the
tyrosine phosphatases LAR (PTPRF), PTPRD and PTPRS38. In
addition, it can simultaneously interact with liprin-β to organize
higher order molecular assemblies39.
We first determined whether R2SP could interact with the
partners of liprin-α2. We fused liprin-α1, liprin-β2 (PPFIBP2),
CASK and RIMS1 to Renilla Luciferase and to flagged Firefly
Luciferase, and performed LUMIER assays with R2SP subunits
(Fig. 7b). Indeed, CASK, liprin-β2 and RIMS1 interacted with
SPAG1. Next, we tested whether R2SP would facilitate the
association of liprin-α2 with its partners. FLAG-FFL-liprin-α2
was transfected in HeLa and HeLa-PIH1D2 cells, and LUMIER
IPs were performed with RL-tagged liprin-α2 partners. Of note, a
larger amount of the FLAG-tagged liprin-α2 plasmid was
transfected in HeLa cells to compensate for its lower level of
expression in this cell line, such that a similar ratio of bait over
preys was obtained in HeLa and HeLa-PIH1D2 cells. The
efficiency of co-precipitation of liprin-α1 by liprin-α2 was similar
in HeLa and HeLa-PIH1D2 cells. In contrast, liprin-β2, CASK,
RIMS1 and PTPRS were all co-precipitated more efficiently by
liprin-α2 in HeLa-PIH1D2 cells (2.3–3.9 fold; Fig. 7c). These data
demonstrate that the presence of PIH1D2, and thus of a full R2SP
complex, promotes the association of liprin-α2 with several of its
targets. This indicates that R2SP is involved in quaternary protein
folding.
Discussion
R2TP is a conserved HSP90 co-chaperone that is involved in the
assembly of key cellular complexes2. S. cerevisiae and human
R2TP share a similar organization but striking differences dis-
tinguish their RPAP3/Tah1p subunit. Human RPAP3 contains
two central TPR domains that bind HSP70 and HSP90, and we
show here that its C-terminal domain adopts a helix-bundle fold
and bind RUVBL1/2 hexamers. In contrast, S. cerevisae Tah1p is
six times smaller than human RPAP3 and consists of a single
short TPR domain that functions as an adapter between Hsp90
and Pih1p15,25. In particular, Tah1p lacks the RPAP3-Cter
homology domain and consequently, the Rvb ATPases are
mainly recruited by Pih1p in yeast26,28. This structural difference
likely translates into different functions. In S. cerevisiae, TAH1
knock-out displays much milder phenotypes than PIH140, while
Drosophila and mouse RPAP3 are essential genes (41 and
unpublished observations).
The PIH domain of PIH1D1 recruits some client proteins via a
phosphopeptide-binding pocket that binds DSpDD/E motifs14,15.
We show here that RPAP3-Cter binds a large number of R2TP
clients and is thus also involved in client recruitment. Interest-
ingly, binding of these clients is lost in RPAP3 mutants that no
longer bind RUVBL1/2. RPAP3-Cter could make cooperative
interactions with RUVBL1/2 to bind the clients, or it may only
bind the ATPases, which would in turn recruit the clients. An
interesting possibility would be that RPAP3-Cter maintains the
ATPases in a conformation suitable for client binding, in a
manner analogous to CDC37 for HSP9042. In agreement with this
idea, RPAP3-Cter has different affinities for RUVBL mutants
locked at different stages of their ATPase cycle.
It was recently proposed that the RUVBLs cycle between single
and double ring structures and that this may give them chaperone
activity 16. Interestingly, dimerization of the hexameric rings
involves their DII domains, and a recent cryo-EM structure of the
S. cerevisiae R2TP complex revealed that the Tah1p:Pih1p het-
erodimer also associates with this domain. The position of Tah1p:
Pih1p thus appears ideal to regulate the formation of double ring
structures. Given the very different interaction of human RPAP3-
PIH1D1 with RUVBL1/2, it will be interesting to determine
whether a similar structural arrangement is conserved in human
R2TP.
SPAG1 has an organization similar to RPAP3, with three TPR
domains preceding the RPAP3-Cter-like domain. We show here
that SPAG1 forms an R2TP-like complex with RUVBL1/2 and
PIH1D2, which we termed R2SP. Our two-hybrid screen indi-
cates that a short region downstream the third TPR of SPAG1 is
involved in PIH1D2 binding (Supplementary Data 2). Interest-
ingly, the difference between the two isoforms of RPAP3 occurs at
a similar location, and this region also determines binding to
PIH1D1 (ref. 33 and Fig. 4b). This is reminiscent of the binding of
Tah1p to Pih1p, where a short C-terminal region of Tah1p,
located immediately downstream the TPR, interacts with the CS
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Fig. 6 Identification of PIH1D2 partners. a Results of yeast two-hybrid screens using human PIH1D2 as bait and performed with human libraries from lung
carcinoma cell lines and testis. The color of the lines indicate the strength of the Y2H interaction (PBS score). a red; b dark blue; c green; d light blue. Lines
with two dots indicate that the prey was found in the two libraries. b Validation of the hits found in the yeast two-hybrid screens by LUMIER co-IP assays.
The graph depicts the results of LUMIER co-IP assays performed with the indicated proteins. Error bars: standard deviation. Stars: values significantly
greater than six-times the mean value obtained in the control IPs without anti-FLAG antibody (Ct). *p-value < 0.05; **p-value < 0.001 (Z-test)
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domain of Pih1p15,25. Taken together, these data suggest a model
in which PIH-like and RPAP3-like proteins interact via an
interface composed of a CS-domain on one side and a short
region downstream the TPRs on the other. This type of interac-
tion may also extend to DYX1C1 since its three isoforms, which
differ in TPR domains and the downstream flanking region,
interact with different PIH partners.
Our interaction assays indicate that cells may contain other
related complexes. First, an R2T complex that contains RPAP3-
iso-2 and RUVBL1/2 but lacks a PIH1-like component. This
complex may be specialized in nuclear functions. Second, an
R2SD complex composed of SPAG1, DNAAF2 and RUVBL1/2. It
was not detected in our proteomic analyses and may thus form
only in specific cell types. Finally, DYX1C1 isoforms associate
with DNAAF2 and PIH1D3 but apparently without binding the
RUVBLs. We do not exclude the possibility that additional pro-
teins may be present, as the prefoldins in the case of R2TP.
Overall, this study highlights the variety of R2TP-like complexes.
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With the exception of PIH1D2, all the R2TP-related proteins
analyzed here have been previously linked to the formation of
cilia and to the assembly of axonemal dyneins29,36,43. Our and
previous evolutionary analysis showed a loss of these proteins
specifically in species lacking cilia (Fig. 1c and 30). However,
several lines of evidence suggest that they have additional func-
tions: (i) R2SP interacts and is involved in the biogenesis of
proteins unrelated to cilia function; (ii) the strongest proteomic
partner of DNAAF2 is RTF1, which is a nuclear protein involved
in transcription; (iii) our CCDC103 two-hybrid screen performed
with a testis library revealed only a few proteins related to cilia
function (see Supplementary Data 2); (iv) GFP-tagged PIH1D3
and DYX1C1-iso-c are predominantly nuclear, with an accu-
mulation in uncharacterized nuclear dots. In the future, it will be
interesting to characterize the various functions of these R2TP-
related proteins and to determine the balance of direct and
indirect effects in cilia formation.
R2SP enrichment in testis could be due to two reasons: (i) it
has testis-specific clients; (ii) it helps ubiquitous proteins to adapt
the particular environment of testis. Our data suggest that both
possibilities occur, since some putative clients of R2SP are enri-
ched in testis, while others are ubiquitous. Indeed, some clients
exhibited a stronger dependency on R2SP at 32 °C, the tem-
perature of testis. This suggests that proteins selected to function
at 37 °C may require additional help to function at 32 °C.
In the case of liprin-α2, we show that R2SP is required for its
expression and association with its partners. Interestingly, the
R2SP subunit SPAG1 binds several liprin-α2 partners while
PIH1D2 binds liprin-α2 itself. This suggests a model in which the
proteins to be assembled are brought together by R2SP, thus
giving them the possibility to interact with each other and to
access the chaperoning activity of the RUVBL1/2 ATPase
(Fig. 7d). The independent recruitment of multiple subunits of
client complexes may be a general mechanism of action for this
class of chaperones.
Liprin-α2 is a conserved scaffolding protein expressed in the
brain and to a lesser extends in testis (Gtex Portal,35). It plays an
important role in neurons, where it participates to the organi-
zation of the synaptic active zone and in the coordinated exo-
cytosis of pre-synaptic vesicles44. Interestingly, the acrosomal
reaction also requires the simultaneous exocytosis of a large
number of vesicles, and this process is also dependent on
liprins45. A parallel has been thus drawn between the synapse and
the acrosome, leading to the term acrosomal synapse46. Since
PIH1D2 is also expressed in the brain, it will be interesting to
determine whether R2SP participates to synaptic transmission,
through its action on liprins.
Methods
Cell culture. HeLa Flp-In cells were a gift of S. Emiliani (Institut Cochin, Paris)47.
HEK293 cells were from the ATCC collection. HeLa Flp-In and HEK293 cells were
grown in Dulbecco’s modified eagle medium (DMEM) containing 10% fetal bovine
serum (FBS), glutamin (2.9 mg/ml), and penicillin/streptomycin (10 U/ml), at 37 °
C, 5% CO2. For SILAC, a 3×-FLAG-GFP tag was fused at the N-terminus of the
indicated proteins and the fusions were stably expressed in HeLa H9 cells by Flp-In
recombination, using the CMV promoter to drive expression48. Clones were
selected in hygromycin (150 μg/ml), picked individually and characterized by
Western blots and fluorescence microscopy.
Plasmids and cloning. DNA cloning was performed using standard techniques
and with the Gateway™ system (InVitrogen). For pairwise two-hybrid tests, plas-
mids were based on pACTII and pAS2ΔΔ 48. For the LUMIER assays, the baits and
preys were expressed in HEK293 cells from the CMV promoter for the 3xFLAG-
FFL fusions, or from the mouse L30 promoter for the RL fusions. The cDNAs were
all of human origin except for RUVBL1 and RUVBL2, which were from mouse.
Plasmids for in vitro expression in Escherichia coli are described below. Detailed
maps and sequences are available upon request. RUVBL1, RUVBL2 are cloned in
the pETDuet vector (Novagen) by manufacturer (GenScript) between NcoI and
HindIII, and NdeI and XhoI, respectively. RPAP3-Cter PCR-amplified fragment
were cloned between the NdeI and BamH1 sites in custom pET-Based vector
(pnEA-3CH, 49) (Supplementary Table 1).
Purification of the human RUVBL1-RUVBL2. RUVBL1 carries an N-terminal
6×His-tag followed by thrombin cleavage site, while RUVBL2 has an N-terminal
FLAG-tag followed by a TEV cleavage site. The RUVBL1-RUVBL2 complex was
expressed in Escherichia coli (DE3) (Novagen, 71400), with 100 µM IPTG over-
night at 18 °C. The complex was immobilized in a 5 ml Histrap TM HP (GE
Healthcare) and eluted with 300 mM imidazole. Anti-Flag M2 Affinity Gel (Sigma)
was used as a second affinity step. FLAG_FH8 tag was cleaved by incubating 18 h at
4 °C with 1% (w/w) HRV-3C protease (Thermo Fisher Scientific). Two size
exclusion steps separated oligomeric species, FLAG_FH8 and protease. Superdex
S200 and Superose 6 column (GE Healthcare) equilibrated in 20 mM Tris–HCl pH
8.0, 150 mM NaCl, 5% glycerol, 2 mM MgCl2 and 0.5 mM TCEP resulted in a
stable dodecameric complex eluting as a single peak from Superose 6 (Supple-
mentary Fig. 2C).
Purification of the human RUVBL1-RUVBL2-RPAP3 complex. RUVBL1 and
RUVBL2 were co-expressed E. coli (DE3; Novagen, 71400) containing the pRARE2
plasmid, during 24 h at 30 °C in EnPresso® B animal-free Media (BioSilta), by
adding 100 µM of IPTG, in a New Brunswick™ (Innova®) 44R Shaker at 225 rpm.
RUVBL1 was described previously50, while RUVBL2 carried a C-terminal
FLAG_FH8 Tag51 preceded by a Human Rhino 3C cleavage site (HRV-3C).
RPAP3535-665 did not any tag.
The RUVBL1-RUVBL2-RPAP3535-665 (R1R2R3) complex was purified, as
described50, but in the presence of ADP and with replacement of the FlagTrap by a
Hydrophobic interaction column (HIC), followed by the Superose 6 column. Peak
fractions collected from the HisTrap were incubated with 5 mM CaCl2 during 1 h
and loaded onto an HiPrepTM Octyl FF 16/10 column (GE Healthcare) equilibrated
in Buffer C (20 mM Tris–HCl pH 8.0, 200 mM NaCl, 5 % glycerol, 2 mM MgCl2, 5
mM CaCl2, 0.5 mM TCEP, 300 µM ADP). Bound proteins were eluted using Buffer
D (Buffer C without CaCl2, supplemented with 5 mM EDTA). To remove the
FLAG_FH8 tag the collected samples were incubated 18 h at 4 °C with 1% (w/w)
HRV-3C protease (Thermo Fisher Scientific). To separate oligomeric species, we
used a Superose 6 column equilibrated in 20 mM Tris–HCl pH 8.0, 150 mM NaCl,
5% glycerol, 2 mM MgCl2, 0.5 mM TCEP and 400 µM ADP. Elution resulted in a
single peak containing a stable R1/R2 hexameric complex bound to RPAP3-Cter
(Fig. 2f). The peak fractions were pooled and concentrated to 12.5 mg/ml using a
10 kDa Cut-off Amicon Ultra centrifugal filter (Millipore). All purification steps
were carried out at room temperature and were monitored by NuPage Bis-Tris gels
(Invitrogen, NP0302).
Purification of RPAP3535-665 and NMR sample preparation. Recombinant 13C/
15N-labeled RPAP3535-665 domain with a cleavable 6xHis-tag were overexpressed in
E. coli (DE3) pRARE2 (Novagen) overnight at 20 °C in a minimal M9 medium
complemented with 15N-NH4Cl and 13C-d6-Glucose and purified on TALON
beads (Clonteth) in 25 mM HEPES, pH 7.5, 300 mM NaCl and eluted from the
resin by cleavage with the HRV-3C protease (GE Healthcare). A final size exclusion
chromatography (S75, GE Healthcare) performed in 10 mM NaPi, pH 6.4, 150 mM
NaCl, and 0.5 mM TCEP provided 15N/13C-labeled samples at a concentration of
1 mM after concentration with Amicon Ultra-15 centrifugal filter unit (Millipore).
Fig. 7 The R2SP complex promotes the stabilization of its clients and the assembly of liprin-α2 complexes. a R2SP enhances expression of some of its
clients. The graph depicts the relative expression levels of the indicated FFL-fusion proteins in HeLa cells expressing PIH1D2, vs. parental HeLa cells not
expressing it. Dark blue: experiment performed at 37 °C; light blue: experiment performed at 32 °C. Values are normalized by the mean of controls (left);
error bars: standard deviation. **p-value < 0.02 with a t-test involving all the control samples (n >= 3). b Binding of PPFIA2-related proteins to SPAG1 and
PIH1D2. The graph depicts LUMIER interaction assays between the indicated proteins. Error bars: standard deviation. Stars: values significantly greater than
six-times the mean value obtained in the control IPs without anti-FLAG antibody (Ct). *p-value < 0.05; **p-value < 0.001 (Z-test). c R2SP promotes
association of liprin-α2 (PPFIA2) with its partners. The graph depicts LUMIER interaction assays between PPFIA2 and its partners, in HeLa cells expressing
or not PIH1D2. Legend as in Fig. 3c, with single black stars indicating a p-value < 0.05, and double black stars a p-value < 0.001 (Z-test comparing values of
the FLAG IPs with six-times the mean value obtained in the control IP). Orange stars: comparison of HeLa and HeLa-PIH1D2 cells. Error bars: standard
deviation. *p-values < 0.05; **p-values < 0.005 (T-test). d Assembly of liprin-α2 complexes by R2SP
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NMR structure calculation. Classical 3D NMR spectra were recorded at 298 K on
a 600MHz AVANCE III spectrometer equipped with a cryoprobe. This permitted
to obtain almost complete 1H, 13C and 15N resonance assignments of RPAP3535-665.
Chemical shifts were referenced to DSS and derived into dihedral angle restraints
with TALOS-N52. Automated procedure of CYANA 3.9753 was then used to derive
distance restraints from 2D 1H-1H NOESY and 3D 15N- and 13C-NOESY-HSQC
spectra, all recorded with a mixing time of 120 ms. The final sets of dihedral angle
and inter-proton restraints were carefully checked and used to generate 100
CYANA structures, which were refined in explicit water using the AMBER-based
Portal Server for NMR structures (AMPS-NMR;54,55). The 20 structures with the
lowest constraint energies were selected as the most representative. In the final set
of structures, 94.3% and 5.7% of the residues lie respectively in the most favored
and allowed regions of the Ramachandran plot. All 3D structures were drawn with
Pymol56.
NMR interaction experiments. 1D METHYL-SOFAST-HMQC spectra were
recorded to monitor the binding of unlabeled RUVBL proteins to 13C-labeled
RPAP3535-665. The 1H dimension was edited, which permitted to only detect 1H
nuclei attached to 13C nuclei. Interaction experiments were performed at 298 K and
at 600MHz in the RUVBL1/2 buffer (20 mM Tris–HCl pH 8.0, 250 mM NaCl, 5%
glycerol, 2 mM MgCl2, 0.5 mM TCEP). RUVBL1 was N-terminally tagged with a
6xHistidine and RUVBL2 with a 3xFLAG. Concentration of 13C-labeled proteins
was around 10 µM. Protons attached to 13C nuclei lying between 5 and 35 ppm
were selectively excited on a band width of 3 ppm and centered at 0 ppm. The
relaxation delay was set to 150 ms and the number of scans to 2048. The final
concentration ratio between unlabeled and labeled proteins was 1:1 (consider-
ing one monomer of RPAP3-Cter and one heterodimer of RUVBL1/2).
Non-denaturing mass spectrometry analysis. For non-denaturing mass spec-
trometry analysis, samples were buffer exchanged against ammonium acetate (150
mM, pH 8.0) buffer (Sigma, St. Louis, MO, USA), using Zeba Spin desalting
columns (Thermo Fisher Scientific, Rockford, IL, USA). Sample concentrations
were determined by UV absorbance using a NanoDrop 2000 spectrophotometer
(Thermo Fisher Scientific, France). Mass spectrometry analyses were carried out on
a hybrid electrospray quadrupole time-of-flight mass spectrometer (Synapt G2
HDMS, Waters, Manchester, UK) coupled to an automated chip-based nanoelec-
trospray source (Triversa Nanomate, Advion Biosciences, Ithaca, U.S.A.) operating
in the positive ion mode. Mass spectrometer calibration was performed using singly
charged ions produced by a 2 mg/ml solution of cesium iodide in 2-propanol/water
(1v/1v) over the m/z range 1000–20,000. Instrumental parameters have been
optimized to get optimal high m/z ion transmission without dissociation of weak
non-covalent interactions by raising the backing pressure to 6 mbar and the cone
voltage to 100 V. Data interpretation was performed using MassLynx 4.1 (Waters,
Manchester, UK).
SPR interaction experiments. RPAP3-Cter protein was immobilized onto CM5
(Series S) sensor chips using standard amine coupling. HBS-N, which consisted of
10 mM HEPES, pH 7.4, 0.15 M NaCl, was used as the background buffer. The
carboxymethyl surface of the chip was activated with 20 mM EDC and 5mM NHS
for 1.5 min. RPAP3535-665 was diluted in 10 mM Sodium Acetate, pH 5.5, to a
concentration of 1 μg/ml. The protein was coupled to the surface with a 1 to 2 min
injection time at a flow rate of 10 μl min−1. The remaining activated groups were
blocked with a 5 min injection of 1.0 M ethanolamine, pH 8.5. Typically, 100 ± 10
response units (RU) were obtained for the immobilization of RPAP3-Cter protein.
Negative controls were performed by immobilizing either Bovine Serum Albumin
(BSA, Thermo Fisher Scientific) or human Cyclophilin D43-207 (CypD) with the
same RU levels as RPAP3-Cter. CypD43-207 is a 22 kDa in-house purified protein
with similar size to RPAP3-Cter and confirmed to be active through binding to
Cyclosporin A. The RUVBL1-RUVBL2 complex was directly dissolved in running
buffer (20 mM NaKPi pH 7.5, 150 mM NaCl, 5 mM MgCl2, 1 mM DTT, 0.05%
P20). The RUVBL1-RUVBL2 complex was tested at 10 different concentrations
using a 2-fold dilution series, with the highest concentration tested being 75.2 nM.
Interaction analysis cycles consisted of a 300 s sample injection (30 µl min−1;
association phase) followed by 600 s of buffer flow (dissociation phase). All sen-
sorgrams were processed by first subtracting the binding response recorded from
the control surface (reference spot), followed by subtracting of the buffer blank
injection from the reaction spot. All datasets were fit to a simple 1:1 Langmuir
interaction model (considering one molecule of RPAP3 binding one hexamer of
RUVBL1/2), to determine the kinetic rate constants. Experiments were performed
on a Biacore 4000 (Biacore AB, GE Healthcare Life Sciences, Uppsala, Sweden) at
25 °C and the interactions were evaluated using the provided Biacore 4000 eva-
luation software.
SILAC proteomics. SILAC experiments were performed as previously described7.
HeLa cells were grown for 15 days in each isotopically labeled media (CIL/Eur-
isotop), to ensure complete incorporation of isotopically labeled arginine and lysine
(light label (K0R0, L) or semi-heavy label L-Lysine-2HCl (2H4, 96–98%)/L-Argi-
nine-HCl (13C6, 99%) (K4R6, M) or L-Lysine-2HCl (13C6, 99%; 15N2, 99%)/L-
Arginine-HCl (13C6, 99%; 15N4, 99%) heavy label (K8R10, H) (percentages
represent the isotopic purity of the labeled amino acids). Six 15-cm diameter plates
were used per SILAC condition. Cells were rinsed with PBS, trypsinized and
cryogrinded in lysis buffer (0.5% triton X-100, 20 mM HEPES, pH 7.4, 150 mM
NaCl, protease inhibitor cocktail). Extracts were incubated 20 min at 4 °C and
clarified by centrifugation for 10 min at 20,000 g. For all IP experiments, extracts
were pre-cleared by incubation with Protein G Sepharose beads (GE healthcare) for
1 h at 4 °C. The control was extracted from the SILAC light condition prepared
from H9 HeLa cells that did not express the GFP fusion. Each extract was then
incubated with 50 µl of GFP-Trap beads (gta-20, Chromotek) for 75 min at 4 °C,
washed five times with lysis buffer, and beads from the different isotopic conditions
were finally pooled. Bound proteins were eluted by adding 1% SDS to the beads and
boiling for 10 min.
Reduction and alkylation were performed on the eluate with DTT (BDH
443553B, 10 mM) for 2 min at 95 °C followed by iodoacetamide treatment (Sigma
I1149, 50 mM) for 30 min in the dark. Proteins were separated by
SDS/PAGE and in gel-digested with trypsin in 20 mM NH4HCO3 (Trypsin Gold,
Promega V5280). Ten slices were cut, and extracted peptides were resuspended in
0.1% formic acid/2% acetonitrile solution before being analyzed by mass
spectrometry. Peptides were analyzed by nano-flow liquid chromatography
coupled to Fourier transform tandem mass spectrometry (nanoLC-FT-MS/MS)
using a LTQ Velos Pro Orbitrap Elite mass spectrometer coupled to an Ultimate
3000 (Thermo Fisher Scientific). Desalting and pre-concentration of samples were
performed on-line on a Pepmap precolumn (0.3 mm 10mm, Thermo Fisher
Scientific) in buffer A (2% acetonitrile, 0.1% formic acid). A gradient consisting of
2–40% buffer B (B= 99.9% acetonitrile with 0.1% formic acid; 3–33 min) and
40–80% B (33–34 min) was used to separate peptides at 300 nL/min from a
Pepmap capillary reversed-phase column (0.075 mm × 150 mm, Thermo Fisher
Scientific). Mass spectra were acquired using a top-20 collision-induced
dissociation (CID) data-dependent acquisition (DDA) method. The Orbitrap was
programmed to perform a FT 400–1,400 Th mass scan (60,000 resolution) with the
top 20 ions in intensity selected for collision-induced dissociation (CID) data-
dependent acquisition (DDA) MS/MS in the LTQ. FT spectra were internally
calibrated using a single lock mass (445.1200 Th). Target ion numbers were
500,000 for FT full scan on the Orbitrap and 10,000 MSn on the LTQ. Data were
acquired using the Xcalibur software v2.2. Protein identification and quantitation
were performed using the program MaxQuant (version 1.5.2.8; http://www.
maxquant.org/). Few parameters were not default: database: human reference
proteome set (canonical isoforms downloaded from Expasy on May 29th 2017);
enzyme specificity trypsin/P; variable modifications: methionine oxidation and
protein N-Acetylation; Fixed modifications: Cysteine carbamidomethylation; MS/
MS tolerance: 0.5 Da; False Discovery Rate (FDR): 1%. In addition to the FDR,
proteins were considered to be identified if they had at least two peptides including
one unique/Razor peptide and they were considered quantified if they had at least
one quantified SILAC pairs. Proteins labeled as REV (non-real proteins from the
reverse database) and CONT (contaminants) were automatically discarded, as well
as proteins that did not show any SILAC M/L, H/L and H/M ratio. B Significance
calculation were done with the software Perseus v1.4.2, as previously described57 to
highlight statistically significant protein ratios (p value < 0.05).
LUMIER assays. HEK293 cells were seeded in 24-well plates and transfected with
450 ng of the RL fusion and 50 ng of the 3xFLAG-FFL fusion, with 1 μl of JetPrime
(PolyPlus), as recommended by the manufacturer. 48 h later, cells were extracted
for 15 min at 4 °C in 450 μl of HNTG containing protease inhibitor cocktail
(Roche), and spun down at 4 °C and at 20,000 × g for 15 min. The IP was per-
formed in duplicated, by putting 100 μl of the extract in each of four wells in a 96-
well plate, with two wells being coated with anti-FLAG antibody (10 μg/ml in 1 ×
PBS; F1804 Sigma-Aldrich), and two control wells without antibodies. Plates were
incubated for 3 h at 4 °C, and then washed 5 times with 300 μl of ice-cold HNTG,
for 10 min at 4 °C for each wash. After the last wash, 10 μl of PBL buffer (Promega)
was added in each well. To measure the input, 2 μl of extract and 8 μl of 1xPBL
buffer was put in empty remaining wells. Plates were then incubated 5 min at room
temperature, and FFL and RL luciferase activities were measured in IP and input
wells, using the dual luciferase kit (Promega). Every transfection was performed at
least twice as independent replicates. Co-IP efficiency was defined as the RL/FFL
ratio in the pellet, divided by the RL/FFL ratio in the input. Unless otherwise stated,
statistical significance was evaluated using Z-test assaying whether the co-IP effi-
ciency in the anti-FLAG IP was more than 6 times higher than the mean values
obtained in the control IP, done without antibodies. This threshold of 6 corre-
sponds to the mean plus two standard deviations of the FLAG/control fold dif-
ference obtained with a set of 36 assays done with non-interacting proteins (see
Supplementary Fig. 4A). It ensures that only specific interactions are identified. The
image of Figs. 3c and 4c and Supplementary Figs. 2D, 4A, and 4B was created by
the authors.
To coat the wells of the 96-well plates with M2 anti-FLAG antibodies, High-
binding plates were used (Lumitrac, Greiner), and 70 μl of M2 antibody (10 μg/ml
in 1× PBS; F1804 Sigma-Aldrich) was put in each well and incubated overnight at
room temperature in the dark. The next day, wells were blocked with 300 μl of
blocking buffer, for 1 hour at room temperature. IP control wells were treated the
same way except that no antibody was put in the well. Blocking buffer was 3% BSA,
5% sucrose, 0.5% Tween 20, 1× PBS). HNTG buffer was 20 mM HEPES-KOH pH
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7.9, 150 mM NaCl, 1% Triton X-100, 10% glycerol, 1 mM MgCl2, 1 mM EGTA.
The values of LUMIER assays used in the bar plots are in Supplementary Data 3.
Luciferase assays. H9 Hela cells were grown on 24-well plates and co-transfected
with plasmids expressing a Flag-tagged Firefly luciferase (FFL) in fusion with the
protein of interest, and with a plasmid coding Renilla luciferase as control (RL).
After 48 h, cells were extracted in 100 µl of 1× PLB buffer (Promega) and incubated
at 4 °C for 15 min. RL and FFL activities were measured on 96-well plates using 10
µl of cell extract and the dual-luciferase assay kit (Promega). Values obtained for
FFL were normalized to RL values. Experiments were done at least in triplicate. The
values used for the bar plot of Fig. 7a are in Supplementary Data 3.
Microscopy. HeLa cells expressing the GFP-fusion of interest were plated on glass
coverslips, fixed one day later, and mounted in Vectashield containing DAPI
(Vector Laboratories). Cells were imaged using an upright epifluorescence
microscope (Zeiss AxioImager Z1,) with a ×63 oil objective (NA 1.4). Images were
captured with a sCMOS camera (Hamamatsu) and mounted in Photoshop.
Genomes and Sequence analyses. Sequences were retrieved from the NCBI
annotated databases (nr and EST, http://www.ncbi.nlm.nih.gov), using NCBI PHI-
BLAST, as well as BLAST and Annotation search tools available in the Geneious
9.1.8 software package (Biomatters, http://www.geneious.com/). Amino acid
sequences were aligned using MAFFT v7.01758. Orthology was determined by
reciprocal BLAST analysis and domain architecture. The accession numbers used
for Fig. 1c and Supplementary 3C are listed in Supplementary Data 4.
Pairwise yeast two-hybrid assays. Plasmids pACT2 and pAS2ΔΔ were intro-
duced into haploid Saccharomyces cerevisiae strains (Y187 and CG1945, respec-
tively)59. Strains were crossed and diploids were selected on –Leu–Trp selective
media and then plated on triple selective media (–Leu–Trp–His). Growth was
assessed visually after 3 days at 30 °C. The strength of interactions was evaluated by
comparing the number of clones growing on –Leu–Trp (selection of diploids) and
–Leu–Trp–His plates (selection for interaction).
Yeast two-hybrid screens. Yeast two-hybrid screening was performed by
Hybrigenics Services, S.A.S., Paris, France (http://www.hybrigenics-services.com).
The coding sequence for full-length (1–315) PIH1D2 (NCBI reference
NM_138789) was PCR-amplified (Supplementary Table 1) and cloned into pB27
plasmid, which derives from pBTM11660. PIH1D1 was fused at the C-terminal end
of LexA (LexA-PIH1D2). Bait sequence integrity was checked by sequencing. Two
random-primed cDNA library were constructed in derivative of the P6 plasmid
pGADGH61, and were used for the screens. The first was made from human testis
cDNAs, and the second one with cDNAs made from three human lung cancer cell
lines: A549, H1703, and H460.
As many as 31 and 51 million clones were screened for the human testis and the
human lung cancer library, respectively. This represents 3-fold and
5-fold the complexity of the respective libraries. A mating strategy was used for the
screens, using on one side L40ΔGal4 (Mata) yeast strains transformed with the bait,
and on the other side the strain YHGX13 (Y187 ade2-101::loxP-kanMX-loxP,
Matα) containing the library, as previously described59. For the testis, screen, 182
His+colonies were selected on a medium lacking tryptophan, leucine and histidine,
while for the lung cancer library, 345 His+colonies were selected on a medium
lacking tryptophan, leucine and histidine and supplemented with 50 mM 3-
aminotriazole to retain an optimal selectivity. Between 2 and 10 million diploid
were tested. The 5′ and 3′ junctions of the prey insert were analyzed by capillary
sequencing after yeast lysis and PCR amplification. The resulting sequences were
compared to Human GenBank (NCBI) for prey identification.
A statistical analysis of the results has been conduct to define a confidence score
(PBS, for Predicted Biological Score), as previously described62. First, the number
of independent prey, the localization of the prey fusion, and the reading frames
were taken into account to define the local score. Second, a global connectivity
study using all the screens conducted at Hybrigenics using the same libraries was
applied. This second analysis identify False positive (Score F), and highly connected
preys (score E). The other score defines a probability for an interaction to be
identify by chance, and are divided in four categories, from A (highest confidence)
to D (lowest confidence). The PBS scores have been shown to positively correlate
with the biological significance of interactions63,64.
Quantification and statistical analysis. Statistical tests were done with Excel.
Data availability. Data supporting the findings of this manuscript are available
from the corresponding authors upon reasonable request. 3D coordinates and
NMR chemical shifts of RPAP3535-665 were deposited in the Protein Data Bank and
in the Biological Magnetic Resonance Data Bank under respective entry codes
6EZ4 and 34200. The SILAC data are accessible in the ProteomeXchange Database
with the following accession numbers: RPAP3-Cter and mutants (PXD009518),
PIH1D2 (PXD009520), PIH1D3 (PXD009499), DNAAF2 (PXD009501),
CCDC103 (PXD009498).
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